Intragraft donor-specific antibodies and lung transplantation Source: Eur Respir J, 54 (5) 1901937; 10.1183/13993003.01937-2019 Year: 2019
Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction Source: Eur Respir J, 54 (5) 1900847; 10.1183/13993003.00847-2019 Year: 2019
Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016
Significance of anti-HLA immunization in lung transplantation Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations Year: 2011
The impact of pre-transplant donor specific anti-HLA antibodies (DSAs) on lung transplant outcome: A single center experience Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019
Pre-transplant soluble CD30 is a stronger predictor of BOS than anti-HLA antibodies occurring after lung transplantation Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007
Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome Source: Eur Respir J, 52 (2) 1701898; 10.1183/13993003.01898-2017 Year: 2018
A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome Source: Eur Respir J, 58 (5) 2004090; 10.1183/13993003.04090-2020 Year: 2021
Evidence of indirect allorecognition of HLA /non-HLA antigens expressed by bronchial epithelial cells from lung transplant recipients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016
T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients Source: Eur Respir J 2006; 28: Suppl. 50, 344s Year: 2006
Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation Source: Eur Respir J 2016; 48: 1807-1810 Year: 2016
Donor and recipient NOD2/CARD15 mutations associate with lung function decline following allogeneic stem cell transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 192s Year: 2006
Pretransplant lung function tests in patients with malignant hemopathy undergoing stem cell transplantation. Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases Year: 2021
The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 178s Year: 2004
Peripheral CD4+CD25+ Treg cell counts and the response to extracorporeal photoapheresis in lung transplant recipients Source: Eur Respir J 2006; 28: Suppl. 50, 723s Year: 2006
Cytomegalovirus-specific cell-mediated immunity after prophylaxis predicts late-onset infection in lung transplantation Source: Virtual Congress 2020 – Clinical management of lung transplant recipients Year: 2020
De novo anti-HLA immunization after lung transplantation: Immunological monitoring and clinical signification Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013
Lung transplantation after allogeneic bone-marrow transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 634s Year: 2005
Immunophenotype and gene signature of long-term survivors with normal allograft function after lung transplantation Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019
Flow-cytometric detection of peripheral CD4+Foxp3+ Treg cells in lung transplant recipients Source: Eur Respir J 2006; 28: Suppl. 50, 120s Year: 2006